New drug for advanced melanoma and other solid tumors
Part of Cancer, Skin clinical trials.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have melanoma or another solid tumor that has spread or cannot be removed with surgery.
- You are willing to give a sample of your tumor (either from a past biopsy or a new one).
- You are able to take care of yourself and do light activities (daily living score 0 or 1).
- You have not had cancer treatment in the last 4 weeks and any side effects from past treatments have improved.
- You do not have active brain metastases, serious heart problems, or an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This study tests a new drug called BL-M09D1 for people with certain gynecologic cancers or other solid tumors that have not responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth, and to check its safety.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
This study tests a new drug called BL-M08D1 for people with nasopharyngeal cancer or other solid tumors that have returned or spread. The trial is in early phases to see how safe the drug is and whether it can shrink tumors.
This trial tests an investigational drug called BL-M09D1 for people with advanced bladder cancer (urothelial carcinoma) or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and help people live longer.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.